全文获取类型
收费全文 | 1213篇 |
免费 | 67篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 57篇 |
妇产科学 | 62篇 |
基础医学 | 121篇 |
口腔科学 | 44篇 |
临床医学 | 118篇 |
内科学 | 259篇 |
皮肤病学 | 11篇 |
神经病学 | 60篇 |
特种医学 | 44篇 |
外科学 | 195篇 |
综合类 | 27篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 56篇 |
眼科学 | 39篇 |
药学 | 87篇 |
中国医学 | 5篇 |
肿瘤学 | 74篇 |
出版年
2023年 | 16篇 |
2022年 | 33篇 |
2021年 | 61篇 |
2020年 | 37篇 |
2019年 | 59篇 |
2018年 | 64篇 |
2017年 | 38篇 |
2016年 | 51篇 |
2015年 | 36篇 |
2014年 | 39篇 |
2013年 | 53篇 |
2012年 | 85篇 |
2011年 | 101篇 |
2010年 | 53篇 |
2009年 | 29篇 |
2008年 | 55篇 |
2007年 | 62篇 |
2006年 | 61篇 |
2005年 | 52篇 |
2004年 | 55篇 |
2003年 | 30篇 |
2002年 | 38篇 |
2001年 | 17篇 |
2000年 | 19篇 |
1999年 | 14篇 |
1998年 | 4篇 |
1997年 | 6篇 |
1996年 | 4篇 |
1995年 | 3篇 |
1993年 | 3篇 |
1992年 | 6篇 |
1991年 | 5篇 |
1990年 | 5篇 |
1989年 | 6篇 |
1988年 | 10篇 |
1987年 | 4篇 |
1986年 | 11篇 |
1985年 | 3篇 |
1984年 | 5篇 |
1983年 | 5篇 |
1982年 | 4篇 |
1981年 | 4篇 |
1979年 | 5篇 |
1978年 | 5篇 |
1976年 | 3篇 |
1975年 | 4篇 |
1974年 | 8篇 |
1971年 | 2篇 |
1970年 | 2篇 |
1968年 | 2篇 |
排序方式: 共有1287条查询结果,搜索用时 484 毫秒
971.
972.
973.
974.
975.
BACKGROUND: The use of dopamine as a renoprotective agent in kidney transplantation remains unclear. Some reports suggest that dopamine improves initial graft function and survival, while others have failed to demonstrate a beneficial effect. Our live-donor nephrectomy program is serviced by 2 senior anesthetists, one who routinely uses dopamine and the other who considers that current evidence does not support a renoprotective effect of dopamine in laparoscopic donor nephrectomy. PURPOSE: We aimed to study the renoprotective effect on donor and recipient renal function of renal-dose dopamine during laparoscopic live-donor nephrectomy (LDN). METHODS: A retrospective analysis was performed of 59 live donor and recipient pairs between 1999 and 2004. Donors were grouped according to whether they received dopamine infusion during LDN. All donors received Hartmann solution to maintain the central venous pressure at 12 mm Hg. The percentage change in serum creatinine (SCr) in both donors and recipients was compared at day 1, day 7, and week 6. RESULTS: In the donors, dopamine infusion had no effect on the mean percentage rise in SCr at day 1 or the mean percentage decrease in SCr at week 6. At day 7, however, patients who received dopamine had a significantly greater decrease in SCr compared with those who did not. In the recipients, there was no significant difference in the mean percentage decrease in SCr at days 1 or 7 or at week 6. Analysis at 1 year revealed no significant difference in sCr among the groups of donors and recipients. CONCLUSIONS: The intraoperative use of renal-dose dopamine during LDN seems to have no beneficial effect for either donor or recipient. 相似文献
976.
Walker I Shehata N Cantin G Couture F Dhédin N Barty R Foley R Sutherland RD Sigouin C Schultz KR Mitchell D;Canadian Blood Marrow Transplant Group 《Blood cells, molecules & diseases》2004,33(3):222-226
BACKGROUND: Canadian multicenter pilot study of haploidentical donor. AIMS: To assess (1) ability to collect suitable graft (CD34+ > or = 5 x 10(6)/kg and CD3 < 1 x 10(5)/kg recipient body weight), (2) toxicity, (3) survival to day +100. ELIGIBILITY: All hematological malignancies and ages; accrual to end after 20 transplants of patients with AML in remission and age less than 55 years. METHODS: Preparation: Modified Perugia regimen, chemotherapy alone; melphalan 140 mg/m2 day -9, thiotepa 10 mg/kg day -7, fludarabine 40 mg/m2 days -7 to -3, and ATG (Thymoglobulin, Sangstat) days -6 to -2 (total 10.5 mg/kg). Infection prophylaxis: Ganciclovir (GC) 5 mg/kg days 5-20 then x5/week until day +100 then x3/week until 210 (subjects 1-3), foscarnet (FC) 90 mg/kg days 4-21 then short course pre-emptive GC or FC (subjects 4-11); fluconazole; cotrimoxazole. Donors: G-CSF 16 microg/kg daily x5 until second pheresis day. T-cell depletion: CliniMACS (MiltenyiBiotec). RESULTS: Eleven patients with AML have been transplanted from four centers, eight female, three male, median age 34 (range 19-60). Disease status, first CR 1/11, second CR 4/11, third CR1/11, relapse 5/11. Graft CD34+ > or = 5 x 10(6)/kg was achieved in all cases, median 13.72 x 10(6)/kg (Q1, Q3: 8.26, 17.72; min 5.59, max 22.22), and CD3+ was < 1 x 10(5)/kg in all cases, median of 0.49 x 10(4)/kg (Q1, Q3: 0.30, 2.20; min 0.22, max 4.10). Ten of the 11 patients have died, median survival 103.5 days (Q1, Q3: 61.0, 151.0; min 0, max 290.0). Survival to day +100 6/11 (55%). Four patients died of leukemic relapse, six of infection. Of six patients dying of infection, CMV was a definite cause in four. Of four dying with relapse, CMV was significant in one. Engraftment was assessed in 10 patients who survived >0 days. Granulocyte engraftment (> 0.5 x 10(9)/l) was achieved in all patients, median 11.5 days (Q1, Q3: 10, 17; min 8, max 70). Platelet engraftment (> 20 x 10(9)/l) was achieved in 8 of 10 patients, median 15 days (Q1, Q3: 9, 16; min 9, max 97). The two platelet non-engrafters died on days +45 and +61. Toxicity was low, with one toxic death (day 0), and the Bearman organ toxicity gradings were < or = grade 2 in all other patients. There were no instances of graft-vs.-host disease or graft rejection. CONCLUSIONS: The problems of graft-vs.-host disease and graft rejection have been removed as barriers to haploidentical transplantation but the slow immune reconstitution limits its general application. Late referrals contribute to a high relapse rate and have delayed an optimal evaluation of the procedure. 相似文献
977.
Cervical dural arteriovenous fistulae manifesting as subarachnoid hemorrhage: report of two cases and literature review 总被引:3,自引:0,他引:3
Aviv RI Shad A Tomlinson G Niemann D Teddy PJ Molyneux AJ Byrne JV 《AJNR. American journal of neuroradiology》2004,25(5):854-858
Dural arteriovenous fistulas (DAVFs) in the craniocervical junction are rare but clinically important. DAVFs can be associated with subarachnoid hemorrhage (SAH), a feature distinguishing them from DAVFs in the thoracolumbar region. These lesions are often overlooked at cerebral angiography performed to assess SAH and account for a small proportion of angiographically negative SAHs. After managing two cases of cervical spinal DAVF manifesting as SAH, we analyzed all cases in the literature to identify features associated with bleeding at presentation. 相似文献
978.
Yaghan R Heis H Bani-Hani K Matalka I Shatanawi N Gharaibeh K Bani-Hani A 《American journal of surgery》2004,187(4):533-537
BACKGROUND: Sources of reports about laparoscopic and percutaneous treatment of liver hydatid cysts are limited to just a few countries. To address the reason behind this, we carried out a survey of 30 surgeons in northern Jordan. METHODS: A questionnaire was distributed to collect data regarding the surgical technique preferred by each surgeon. Further information was collected from those not adopting minimal-access techniques to determine their reasons for not doing so. RESULTS: Only 3 surgeons (10%) considered laparoscopy as the first line of treatment. Of the 27 surgeons who did not consider percutaneous or laparoscopic treatment, fear of anaphylaxis and/or dissemination was the main reason given by 21 surgeons (78%) for not using minimal access techniques. CONCLUSIONS: The seemingly exaggerated traditional fear of anaphylaxis seems to discourage surgeons from more widely adopting minimal access techniques for the treatment of hydatid cyst. 相似文献
979.
980.
Abdominal aortic aneurysms (AAAs) are not only a danger in themselves, they also signify underlying vascular disease that warrants intensive cardiovascular risk reduction, especially smoking cessation. Aneurysmal size and the patient's fitness for surgery are the main determinants of timing and method of elective repair. The choice of open surgery vs endovascular repair depends on the patient's condition, preference, and life expectancy, and the surgeon's experience. 相似文献